PELL Bio-Med Technology Co (TPE:6949) Research & Development: NT$252.66 Mil (TTM As of Dec. 2025)


TPE:6949 PELL Bio-Med Technology Co Ltd TPE:6949
13 GF Score
Price NT$862.00
! 5 Warning Signs
View Full Analysis

What is PELL Bio-Med Technology Co Research & Development?

PELL Bio-Med Technology Co TPE:6949 -1.93% 13 Research & Development is NT$252.66 Mil as of Dec. 2025. GuruFocus rates TPE:6949 with a GF Score™ of 13/100. The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. PELL Bio-Med Technology Co's Research & Development for the three months ended in Dec. 2025 was NT$74.30 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was NT$252.66 Mil.

PELL Bio-Med Technology Co  (TPE:6949) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

PELL Bio-Med Technology Co Research & Development Related Terms

PELL Bio-Med Technology Co Research & Development Historical Data

* Premium members only.

The historical data trend for PELL Bio-Med Technology Co's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

PELL Bio-Med Technology Co Research & Development Chart

PELL Bio-Med Technology Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
136.82 142.55 239.61 266.16 252.66

PELL Bio-Med Technology Co Quarterly Data
Dec21 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.79 51.34 45.36 81.66 74.30
TPE:6949
13GF Score
PELL Bio-Med Technology Co Ltd TPE:6949
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

PELL Bio-Med Technology Co Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was NT$252.66 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of NT$252.66 Mil mean?
PELL Bio-Med Technology Co (TPE:6949) has a Research & Development of NT$252.66 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on PELL Bio-Med Technology Co and its competitors.
Is PELL Bio-Med Technology Co's Research & Development too high?
PELL Bio-Med Technology Co's current Research & Development is NT$252.66 Mil. Overall, PELL Bio-Med Technology Co has a GF Score™ of 13/100, reflecting its overall financial health beyond just this single metric.
How does PELL Bio-Med Technology Co's Research & Development compare to VRTX and REGN?
PELL Bio-Med Technology Co's Research & Development of NT$252.66 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Biotechnology company?
A good Research & Development depends on the Biotechnology industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on PELL Bio-Med Technology Co and its competitors. PELL Bio-Med Technology Co's current Research & Development is NT$252.66 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PELL Bio-Med Technology Co stock overvalued right now?
PELL Bio-Med Technology Co (TPE:6949) has a current Research & Development of NT$252.66 Mil. The current Research & Development is NT$252.66 Mil. PELL Bio-Med Technology Co's overall GF Score™ is 13/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For PELL Bio-Med Technology Co (TPE:6949), the current Research & Development is NT$252.66 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

PELL Bio-Med Technology Co Business Description

Address No. 87, Xinhu 2nd Road, 4th Floor, Neihu District, Taipei, TWN
PELL Bio-Med Technology Co Ltd is a company engaged in the research and development and application of autologous T Cell Therapy (Adoptive T Cell Therapy), CAR-T (Chimeric Antigen Receptor T cell), and Gene-Modified Adipose-Derived Stem Cell (Gene-Modified Adipose-Derived Stem Cell). The company's segments includes Cell products, Consulting services, and Others.
13GF Score

Get the complete analysis for TPE:6949

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$862.00
Price